|
Volumn 42, Issue 1069, 2000, Pages 1-6
|
Drug for HIV infection
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
AMPRENAVIR;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
INDINAVIR;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
NELFINAVIR;
NEVIRAPINE;
RITONAVIR;
SAQUINAVIR;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
2',3' DIDEOXYNUCLEOSIDE DERIVATIVE;
ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
ANTIVIRAL ACTIVITY;
BLOOD TOXICITY;
ENZYME INHIBITION;
GASTROINTESTINAL TOXICITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPOTENSION;
KIDNEY FAILURE;
MALAISE;
NEUROTOXICITY;
PANCREATITIS;
RASH;
RESPIRATORY DISTRESS;
REVIEW;
TOXIC HEPATITIS;
VIRUS INHIBITION;
ARTICLE;
DISEASE TRANSMISSION;
DRUG COMBINATION;
DRUG COST;
ECONOMICS;
FEMALE;
PREGNANCY;
PREGNANCY COMPLICATION;
ANTI-HIV AGENTS;
DIDANOSINE;
DIDEOXYNUCLEOSIDES;
DISEASE TRANSMISSION, VERTICAL;
DRUG COSTS;
DRUG THERAPY, COMBINATION;
FEMALE;
HIV INFECTIONS;
HUMANS;
LAMIVUDINE;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
REVERSE TRANSCRIPTASE INHIBITORS;
STAVUDINE;
ZALCITABINE;
ZIDOVUDINE;
|
EID: 0034627425
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (8)
|
References (0)
|